In-vitro Toxicology Testing Market to grow with a CAGR of 9.66% through 2028
Growing
demand of the safety of new drugs and Environmental monitoring are the major
drivers for the Global In-Vitro Toxicology Testing Market.
According
to TechSci Research report, “In-Vitro Toxicology Testing Market –Global
Industry Size, Share, Trends, Competition, Opportunity and Forecast,
2018-2028”, the Global Dyes Market stood at USD 16.09 Billion in 2022 and
is anticipated to project robust growth in the forecast period with a CAGR of
9.66% through 2028. This can be ascribed to collaborations and partnerships
among leading companies with a diverse approach to merge the expertise of
individual companies and to strengthen their position in the market.
In-vitro
toxicology testing is a scientific approach used to assess the potential
toxicity of chemicals, drugs, consumer products, and other substances using
isolated cells, tissues, or cellular components outside of a living organism.
Significant growth in the healthcare industry across the globe represents one
of the key factors creating a positive outlook for the market. Furthermore, the
increasing demand for Public Health and Consumer Safety and media and advocacy
industries is also driving the market growth. These apparel industries are
consumer-based, contributing to the economy by providing trade along the
technology and applications. The demand for in-vitro toxicology testing is
prevalent across several industries and sectors where safety assessment, risk
evaluation, and regulatory compliance are crucial.
Therefore,
the increasing demand in the pharmaceutical and biotechnology industry will
drive the Toxicology Testing market. In-vitro toxicology testing is extensively
used in drug discovery and development to assess the safety and potential
toxicity of new drug candidates. It helps identify compounds with adverse
effects, optimize lead candidates, and reduce the likelihood of unexpected
toxicity during clinical trials. Moreover, leading players operating in the
industry are focusing on product innovations to offer a better customer
experience. They are also engaging in partnerships and collaborations to
increase their brand presence. Apart from this, Chemical manufacturers rely on
in-vitro toxicology testing to evaluate the safety of new chemicals, industrial
materials, and chemical products. This includes assessing potential hazards,
such as cytotoxicity, genotoxicity, and carcinogenicity, before these
substances are introduced into the market.
Browse
over XX market data Figures and spread through XX Pages and an in-depth
TOC on "Global In-vitro Toxicology Testing Market.”
Moreover,
In-vitro toxicology testing is essential for evaluating the safety of
cosmetics, skincare products, and other personal care items. It helps ensure
that these products do not cause adverse effects on skin, eyes, or other
tissues. This, along with the rising demand for reduced animal testing, is
driving the market. Government initiatives play a significant role in shaping
the development, adoption, and regulatory acceptance of in-vitro toxicology
testing methods globally. These initiatives aim to promote alternatives to
animal testing, improve safety assessment practices, and enhance human and
environmental health protection. There is a growing emphasis on Human-relevant
models within the healthcare industry, There is a strong emphasis on developing
and using human-relevant models, such as human-derived cells and tissues, to
improve the accuracy and relevance of toxicity assessments. These models better
predict human responses and reduce reliance on animal testing.
Additionally,
the Registration, Evaluation, Authorization, and Restriction of Chemicals
(REACH) regulation in the European Union promotes the use of alternative
testing methods, including in-vitro methods, to assess the safety of chemicals.
It encourages the development and validation of alternative approaches and
provides regulatory incentives for their adoption. The Tox21 program, led by
the National Toxicology Program (NTP), the National Institutes of Health (NIH),
and the U.S. Environmental Protection Agency (EPA), aims to improve chemical
safety testing through high-throughput in-vitro and computational approaches.
It focuses on identifying potential health risks associated with environmental
chemicals. These projects serve as tangible examples of innovation and
encourage other industry players to embrace similar approaches. Through
strategic partnerships, brands, manufacturers, and Testing players can
collaborate to implement sustainable practices.
The
Charles River laboratories international, Inc. (CRL) announced today the
scheduled opening of the Charles River accelerator and development lab, Charles
River Accelerator®, in Seattle and Philadelphia. Charles River Accelerator®
Seattle is Charles River’s latest investment in Seattle. The company’s first
facility opened in 2021 in response to the rapidly expanding city’s position as
a leading life sciences center with strong start-up and business growth. CRADL®
Seattle is set to open this September and responds to the growing demand for
more dynamic vivarium space, as well as in vivo on-demand study support
services. As a leading contract vivarium provider, Charles River Laboratories
International (CRL) is committed to expanding the capacity of its biopharmaceutical
facilities to meet the growing demands of the industry.
However,
complexity of biological system and long term and chronic effects are expected
to slow down the growth of the market in the coming years.
The
Global In-vitro Toxicology Testing Market segmentation is based on Technology,
Application, Method, End-User, By Company, and Region.
Some of the
major companies operating in the Global In-vitro Toxicology Testing Market
include:
- Charles
River Laboratories International, Inc.
- SGS
S.A.
- Merck
KGaA
- Eurofins
Scientific
- Abbott
Laboratories
- Laboratory
Corporation of America Holdings
- Evotec
S.E.
- Thermo
Fisher Scientific, Inc.
- Quest
Diagnostics Incorporated
- Agilent
Technolgies, Inc.
- Catalent,
Inc.
Download Free Sample Report
Customers can also request for 10% free customization on
this report.
“Certain
regions, particularly the North-America, are projected to exert significant
demand for In-Vitro Toxicology Testing worldwide. The growth in the competitive
landscape and the presence of well-established companies in the market,
committed to enhancing their technological advancement each year, are expected
to contribute to a remarkable growth of the Global In-Vitro Toxicology Testing
Market in the forecast period," said Mr. Karan Chechi, Research Director
with TechSci Research, a research-based Global management consulting firm.
In-vitro
Toxicology Testing Market - Global Industry Size, Share, Trends, Opportunity,
and Forecast, 2018-2028 Segmented By Technology (Cell Culture Technology, High
Throughput Technology, Molecular Imaging, OMICS Technology), By Application
(Systemic Toxicology, Dermal Toxicity, Endocrine Disruption, Occular Toxicity,
Others), By Method (Cellular Assay, Biochemical Assay, In-Silico, Ex-Vivo), By
End-User (Pharmaceutical Industry, Cosmetics & Household Products, Academic
Institutes & Research Laboratories, Diagnostics, Chemicals Industry, Food
Industry), By Region, Competition
has evaluated the future growth potential of Global In-vitro Toxicology Testing
Market and provides statistics & information on market size, structure, and
future market growth. The report intends to provide innovative market
intelligence and help decision makers take sound investment decisions. Besides,
the report also identifies and analyzes the emerging trends along with
essential drivers, challenges, and opportunities in Global In-vitro Toxicology
Testing Market.
Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel: +1-646-360-1656
Email: [email protected]
Website: https://www.techsciresearch.com